Correlation Between PDS Biotechnology and Aravive
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Aravive, you can compare the effects of market volatilities on PDS Biotechnology and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Aravive.
Diversification Opportunities for PDS Biotechnology and Aravive
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between PDS and Aravive is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Aravive go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Aravive
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 1.01 times more return on investment than Aravive. However, PDS Biotechnology is 1.01 times more volatile than Aravive. It trades about -0.03 of its potential returns per unit of risk. Aravive is currently generating about -0.83 per unit of risk. If you would invest 576.00 in PDS Biotechnology Corp on September 12, 2024 and sell it today you would lose (362.00) from holding PDS Biotechnology Corp or give up 62.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Aravive
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PDS Biotechnology and Aravive Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Aravive
The main advantage of trading using opposite PDS Biotechnology and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |